Skip to main content
SpringerLink
Log in

Acute Coronary Syndrome: Where We Are, How We Got Here, and Where We Are Going

  • Chapter
Book cover Acute Coronary Syndrome

  • 1656 Accesses

Advances in the treatment of acute coronary syndrome (ACS) can justifi ably be considered one of the great achievements of modern medicine. The evolution of treatment strategies from “benign neglect” in the early 1900s to an aggressive interventional approach with devices and potent pharmacotherapy in the 2000s represents a remarkable achievement.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Fye WB. Acute myocardial infarction: a historical summary. In: Gersh BJ, Rahimtoola SH, eds. Acute myocardial infarction. 2nd ed. New York: Chapman and Hall; 1997:1–5.

    Google Scholar 

  2. Krehl L. Die Ekrankungen des Herzmuskels und die Nervosen Herzkrankheiten. Vienna: Alfred Holder; 1901.

    Google Scholar 

  3. Herrick JB. Certain clinical features of sudden obstruction of the coronary arteries. JAMA 1912;59:2015–2020.

    Google Scholar 

  4. Parkinson J, Bedford E. Cardiac infarction and coronary thrombosis. Lancet 1928; 1:4–11.

    Article  Google Scholar 

  5. Levine SA. Coronary thrombosis: its various clinical features. Medicine 1929; 8:245–418.

    Article  Google Scholar 

  6. Levine SA, Lown B. Armchair treatment of acute coronary thrombosis. JAMA 1952; 148:1365–1369.

    CAS  Google Scholar 

  7. Harrison TR, Resnik WH. Etiologic aspects of heart disease (including treatment of the different etiologic types). In: Harrison TR, Beeson PB, Resnik WH, Thom GW, Wintrobe MM, eds. Principles of internal medicine. 2nd ed. New York: The Balkiston Co., 1950:1285–1289.

    Google Scholar 

  8. Julian DG. Treatment of cardiac arrest in acute myocardial ischemia and infarction. Lancet 1961;ii:840–844.

    Article  Google Scholar 

  9. Pantridge JF, Geddes JS. A mobile coronary care unit in the management of myo-cardial infarction. Lancet 1967;2:271–273.

    Article  PubMed  CAS  Google Scholar 

  10. International Collaborative Study Group (ICSG). Reduction of infarct size with the early use of timolol in acute myocardial infarction. N Engl J Med 1984;310:9–15.

    Article  Google Scholar 

  11. Davies MJ, Thomas AC. Plaque fissuring—the cause of acute myocardial infarction, sudden ischemic death, and crescendo angina. Br Heart J 1985;53:363–373.

    Article  PubMed  CAS  Google Scholar 

  12. Fletcher AP, Sherry S, Alkjaersig H, et al. The maintenance of a sustained thrombo-lytic state in man. II. Clinical observations on patients with myocardial infarction and other thromboembolic disorders. J Clin Invest 1959;38:1111–1119.

    Article  PubMed  CAS  Google Scholar 

  13. Verstraete M. Thrombolytic therapy in recent myocardial infarction. In: Meltzer LE, Dunning AJ, eds. Textbook of coronary care. Amsterdam: Excerpta Medica; 1972:643–659.

    Google Scholar 

  14. Chazov El, Matveeva LS, Mazaev AV, et al. Intracoronary administration of fibrino-lysin in acute myocardial infarction. Terapeuticheskds Arkhiv 1976;48:8–19.

    CAS  Google Scholar 

  15. Rentrop KP, Blanke H, Karsch KR, et al. Acute myocardial infarction: intracoronary application of nitroglycerin and streptokinase. Clin Cardiol 1979;2:354–363.

    PubMed  CAS  Google Scholar 

  16. Gruppo Italiano per to Studio della Streptochinasi nell'Infarto Miocardico (GISSI). Effectiveness of intravenous thrombolysic treatment in acute myocardial infarction. Lancet 1986;1:397–402.

    Google Scholar 

  17. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 1988;2:349–360.

    Google Scholar 

  18. The TIMI Study Group. The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. N Engl J Med 1985;312:932–936.

    Google Scholar 

  19. The GUSTO Investigators. An international randomized trial comparing four thrombolysic strategies for acute myocardial infarction. N Engl J Med 1993;329:673–682.

    Article  Google Scholar 

  20. The TIMI IIIB Investigators. Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q wave myocardial infarction. Results of the TIMI IIIB Trial. Circulation 1994;89:1545–1556.

    Google Scholar 

  21. Hamm CV, Goldmann BU, Heeschen C, et al. Emergency room triage of patients with acute chest pain by means of rapid testing for cardiac troponin T or troponin I. N Engl J Med 1997;337:1648–1653.

    Article  PubMed  CAS  Google Scholar 

  22. Polanczyk CA, Lee TH, Cook EF, et al. Cardiac troponin I as a predictor of major cardiac events in emergency department patients with acute coronary care syndromes. J Am Coll Cardiol 1998;32:8–14.

    Article  PubMed  CAS  Google Scholar 

  23. Grüntzig A, Hopff H. Perkutane Rekanalisation chronischer arterieller Verschlüsse mit einem neuen Dilatationskatheter. Dtsch Med Wochenschr 1974;99:2502–2505.

    Article  PubMed  Google Scholar 

  24. Hurst JW. The first coronary angioplasty as described by Andreas Gruentzig. Am J Cardiol 1986;57:185–186.

    Article  PubMed  CAS  Google Scholar 

  25. Grines CL, Browne KF, Marco J, et al., for the Primary Angioplasty in Myocardial Infarction Study Group. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. N Engl J Med 1993;328:673–679.

    Article  PubMed  CAS  Google Scholar 

  26. Armstrong PW, Fu Y, Chang WC, et al., for the GUSTO-IIb Investigators. Acute coronary syndromes in the GUSTO-IIb trial: prognostic insights and impact of recurrent ischemia. Circulation 1998;98:1860–1868.

    PubMed  CAS  Google Scholar 

  27. Weaver WD, Simes RJ, Betriu A, et al. Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review. JAMA 1997;278:2093–2098.

    Article  PubMed  CAS  Google Scholar 

  28. Grines CL, Cox DA, Stone GW, et al., for the Stent Primary Angioplasty in Myocar-dial Infarction Study Group. Coronary angioplasty with or without stent implantation for acute myocardial infarction. N Engl J Med 1999;341:1949–1956.

    Article  PubMed  CAS  Google Scholar 

  29. Stone GW, Grines CL, Cox DA, et al. Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction. N Engl J Med 2002;346:957–966.

    Article  PubMed  CAS  Google Scholar 

  30. Moses JW, Leon MB, Popma JJ, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003;349:1315–1323.

    Article  PubMed  CAS  Google Scholar 

  31. Morice MC, Serruys PW, Sousa JE, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002;346:1773–1780.

    Article  PubMed  CAS  Google Scholar 

  32. Serruys PW, Degertekin M, Tanabe K, et al. Intravascular ultrasound findings in the multicenter, randomized, double-blind RAVEL (RAndomized study with the sirolimus-eluting VElocity balloon-expandable stent in the treatment of patients with de novo native coronary artery Lesions) trial. Circulation 2002;106:798–803.

    Article  PubMed  CAS  Google Scholar 

  33. Stone GW, Ellis SG, Cox DA, et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 2004;350:221–231.

    Article  PubMed  CAS  Google Scholar 

  34. Cannon CP, Weintraub WS, Demopoulos LA, et al. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med 2001;344:1879– 1887.

    Article  PubMed  CAS  Google Scholar 

  35. Fox K, Poole-Wilson P, Henderson R, et al. Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the British Heart Foundation RITA 3 randomised trial. Lancet 2002;360:743–751.

    Article  PubMed  CAS  Google Scholar 

  36. Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results of the TIMI IIIB Trial. Thrombolysis in Myocardial Ischemia. Circulation 1994;89:1545–1556.

    Google Scholar 

  37. Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study. FRagmin and Fast Revasculari-sation during Instability in Coronary artery disease Investigators. Lancet 1999;354:708–715.

    Google Scholar 

  38. Neumann FJ, Kastrati A, Pogatsa-Murray G, et al. Evaluation of prolonged anti-thrombotic pretreatment (“cooling-off” strategy) before intervention in patients with unstable coronary syndromes: a randomized controlled trial. JAMA 2003;290:1593–1599.

    Article  PubMed  CAS  Google Scholar 

  39. Liuzzo G, Biasucci LM, Gallimore JR, et al. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med 1994;331:417–424.

    Article  PubMed  CAS  Google Scholar 

  40. Morrow DA, Rifai N, Antman EM, et al. C-reactive protein is a potent predictor of mortality independently and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy. J Am Coll Cardiol 1998;31:1460–1465.

    Article  PubMed  CAS  Google Scholar 

  41. Biasucci LM, Liuzzo G, Grillo RL, et al. Elevated levels of C-reactive protein at discharge in patients with unstable angina predict recurrent instability. Circulation 1999;99:855–860.

    PubMed  CAS  Google Scholar 

  42. Schwartz GG, Olsson AG, Ezekowitz MD, et al. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes. The MIRACL Study: a randomized controlled trial. JAMA 2001;285:1711–1718.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Cardiology Department of Emergency Medicine, St. Luke's-Roosevelt Hospital Center Columbia University College of Physicians and Surgeons, New York, NY, USA

    Jayanthi N. Koneru MD, Lance W. Weathers MD & Michael Lesch MD

Authors
  1. Jayanthi N. Koneru MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lance W. Weathers MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Michael Lesch MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Cardiac Catheterization Laboratory and Interventional Cardiology, Department of Medicine, St. Luke's-Roosevelt Hospital Center, Columbia University College of Physicians and Surgeons, New York, NY, USA

    Mun K. Hong MD

  2. Cardiac Care Unit, St. Luke's-Roosevelt Hospital Center, Columbia University College of Physicians and Surgeons, New York, NY, USA

    Eyal Herzog MD, FACC

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Springer-Verlag London Limited

About this chapter

Cite this chapter

Koneru, J.N., Weathers, L.W., Lesch, M. (2008). Acute Coronary Syndrome: Where We Are, How We Got Here, and Where We Are Going. In: Hong, M.K., Herzog, E. (eds) Acute Coronary Syndrome. Springer, London. https://doi.org/10.1007/978-1-84628-869-2_1

Download citation

  • DOI: https://doi.org/10.1007/978-1-84628-869-2_1

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-84628-868-5

  • Online ISBN: 978-1-84628-869-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation